Amidephrine

DB16623

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 244.31
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

148 Data
Benzylpenicilloyl polylysine Amidephrine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Spironolactone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Spironolactone.
Methysergide Methysergide may increase the hypertensive and vasoconstricting activities of Amidephrine.
Cabergoline Cabergoline may increase the hypertensive and vasoconstricting activities of Amidephrine.
Dihydroergotamine Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Methylergometrine Methylergometrine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Lisuride Lisuride may increase the hypertensive and vasoconstricting activities of Amidephrine.
Ergotamine Ergotamine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Nicergoline Nicergoline may increase the hypertensive and vasoconstricting activities of Amidephrine.
Ergoloid mesylate Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Amidephrine.
Pergolide Pergolide may increase the hypertensive and vasoconstricting activities of Amidephrine.
Bromocriptine Bromocriptine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Ergometrine Ergometrine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Lysergic acid diethylamide Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Amidephrine.
Dihydroergocornine Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Dihydroergocristine Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Dihydroergocryptine Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Amidephrine.
Terguride Terguride may increase the hypertensive and vasoconstricting activities of Amidephrine.
Metergoline Metergoline may increase the hypertensive and vasoconstricting activities of Amidephrine.
Venlafaxine Venlafaxine may increase the tachycardic activities of Amidephrine.
Duloxetine Duloxetine may increase the tachycardic activities of Amidephrine.
Sibutramine Sibutramine may increase the tachycardic activities of Amidephrine.
Nefazodone Nefazodone may increase the tachycardic activities of Amidephrine.
Milnacipran Milnacipran may increase the tachycardic activities of Amidephrine.
Desvenlafaxine Desvenlafaxine may increase the tachycardic activities of Amidephrine.
Levomilnacipran Levomilnacipran may increase the tachycardic activities of Amidephrine.
Ziprasidone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Ziprasidone.
Amitriptyline The therapeutic efficacy of Amidephrine can be decreased when used in combination with Amitriptyline.
Olanzapine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Olanzapine.
Alfuzosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Alfuzosin.
Clozapine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Clozapine.
Promazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Promazine.
Droperidol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Droperidol.
Prazosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Prazosin.
Imipramine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Imipramine.
Chlorpromazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Chlorpromazine.
Nortriptyline The therapeutic efficacy of Amidephrine can be decreased when used in combination with Nortriptyline.
Amoxapine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Amoxapine.
Doxazosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Doxazosin.
Nicardipine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Nicardipine.
Trazodone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Trazodone.
Verapamil The therapeutic efficacy of Amidephrine can be decreased when used in combination with Verapamil.
Thioridazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Thioridazine.
Phentolamine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Phentolamine.
Tamsulosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Tamsulosin.
Trimipramine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Trimipramine.
Risperidone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Risperidone.
Propiomazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Propiomazine.
Tolazoline The therapeutic efficacy of Amidephrine can be decreased when used in combination with Tolazoline.
Trifluoperazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Trifluoperazine.
Flupentixol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Flupentixol.
Quinidine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Quinidine.
Phenoxybenzamine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Phenoxybenzamine.
Doxepin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Doxepin.
Terazosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Terazosin.
Quetiapine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Quetiapine.
Aripiprazole The therapeutic efficacy of Amidephrine can be decreased when used in combination with Aripiprazole.
Paliperidone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Paliperidone.
Methotrimeprazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Methotrimeprazine.
Periciazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Periciazine.
Acepromazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Acepromazine.
Thioproperazine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Thioproperazine.
Zuclopenthixol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Zuclopenthixol.
Dronedarone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Dronedarone.
Iloperidone The therapeutic efficacy of Amidephrine can be decreased when used in combination with Iloperidone.
Pizotifen The therapeutic efficacy of Amidephrine can be decreased when used in combination with Pizotifen.
Silodosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Silodosin.
Asenapine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Asenapine.
Indoramin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Indoramin.
Brexpiprazole The therapeutic efficacy of Amidephrine can be decreased when used in combination with Brexpiprazole.
Trimazosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Trimazosin.
Niguldipine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Niguldipine.
Bunazosin The therapeutic efficacy of Amidephrine can be decreased when used in combination with Bunazosin.
Propiverine The therapeutic efficacy of Amidephrine can be decreased when used in combination with Propiverine.
Urapidil The therapeutic efficacy of Amidephrine can be decreased when used in combination with Urapidil.
Aripiprazole lauroxil The therapeutic efficacy of Amidephrine can be decreased when used in combination with Aripiprazole lauroxil.
Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Amidephrine.
Desipramine The risk or severity of hypertension can be increased when Desipramine is combined with Amidephrine.
Clomipramine The risk or severity of hypertension can be increased when Clomipramine is combined with Amidephrine.
Amineptine The risk or severity of hypertension can be increased when Amineptine is combined with Amidephrine.
Dimetacrine The risk or severity of hypertension can be increased when Dimetacrine is combined with Amidephrine.
Butriptyline The risk or severity of hypertension can be increased when Butriptyline is combined with Amidephrine.
Dosulepin The risk or severity of hypertension can be increased when Dosulepin is combined with Amidephrine.
Tianeptine The risk or severity of hypertension can be increased when Tianeptine is combined with Amidephrine.
Oxaprotiline The risk or severity of hypertension can be increased when Oxaprotiline is combined with Amidephrine.
Opipramol The risk or severity of hypertension can be increased when Opipramol is combined with Amidephrine.
Amitriptylinoxide The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Amidephrine.
Dibenzepin The risk or severity of hypertension can be increased when Dibenzepin is combined with Amidephrine.
Quinupramine The risk or severity of hypertension can be increased when Quinupramine is combined with Amidephrine.
Melitracen The risk or severity of hypertension can be increased when Melitracen is combined with Amidephrine.
Lofepramine The risk or severity of hypertension can be increased when Lofepramine is combined with Amidephrine.
Iprindole The risk or severity of hypertension can be increased when Iprindole is combined with Amidephrine.
Imipramine oxide The risk or severity of hypertension can be increased when Imipramine oxide is combined with Amidephrine.
Labetalol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Labetalol.
Carvedilol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Carvedilol.
Bevantolol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Bevantolol.
Bucindolol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Bucindolol.
Esmolol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Esmolol.
Betaxolol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Betaxolol.
Metoprolol The therapeutic efficacy of Amidephrine can be decreased when used in combination with Metoprolol.

Target Protein

Alpha-2C adrenergic receptor ADRA2C

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul